Synopsis
Synopsis
0
JDMF
0
VMF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. By 1023
2. By-1023
3. By1023
4. Pantoprazole
5. Protonix
6. Sk And F 96022
7. Sk And F-96022
8. Sk And F96022
9. Skf 96022
10. Skf-96022
11. Skf96022
1. 138786-67-1
2. Pantoloc
3. Protonix
4. Pantecta
5. Zurcal
6. Pantoprazole Sodium Salt
7. Skf96022 Sodium
8. By-1023 Sodium
9. Chebi:50270
10. Sodium;5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
11. Pantozol Control
12. 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl) Sulfinyl)-1h-benzimidazole Sodium
13. Dsstox_cid_24215
14. Dsstox_rid_80123
15. Dsstox_gsid_44215
16. Sodium 5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)benzo[d]imidazol-1-ide
17. Sodium 5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)benzo[d]imidazol-1-ide
18. Cas-138786-67-1
19. Anagastra
20. Inipomp
21. Pantorc
22. Peptazol
23. Ulcotenal
24. Citrel
25. Apton
26. Rifun
27. Pantoprazole Sodium;
28. By1023 (sodium)
29. Pantoprazole Sodium,(s)
30. Skf96022 (sodium)
31. Schembl3543
32. Mls001424073
33. Pantoprazole Sodium Monohydrate
34. Chembl1200408
35. Dtxsid7044215
36. Dz-2352a
37. Hms2051l19
38. Hms3393l19
39. Hms3715d12
40. Act02633
41. Tox21_112996
42. Tox21_302362
43. Mfcd01658543
44. S4538
45. Akos015994677
46. Ccg-100980
47. Ks-1093
48. Nc00230
49. S86p671
50. Sb17369
51. By-1023/sk&f-96022
52. Ncgc00255835-01
53. Smr000469592
54. Ft-0602602
55. Ft-0673508
56. A807440
57. B-8610-23/sk&f-96022-z
58. J-516336
59. B-8510-29
60. Q27122012
61. Sodium 5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl] Benzimidazol-1-ide
62. 5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1h-benzo[d]imidazole, Sodium Salt
63. 5-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]benzimidazol-1-ide; Sodium;pantoprazole Sodium
64. Sodium 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole
65. Sodium 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide
1. Pantozol
2. S-pantoprazole
3. Pantoprazole
Molecular Weight | 405.4 g/mol |
---|---|
Molecular Formula | C16H14F2N3NaO4S |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 7 |
Exact Mass | 405.05707772 g/mol |
Monoisotopic Mass | 405.05707772 g/mol |
Topological Polar Surface Area | 90.8 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 497 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Pantoprazole sodium |
Drug Label | The active ingredient in pantoprazole sodium delayed-release tablets USP is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid... |
Active Ingredient | Pantoprazole sodium |
Dosage Form | Injectable; Tablet, delayed release |
Route | injection; Iv (infusion); Oral |
Strength | eq 20mg base; eq 40mg base/vial; eq 40mg base; 40mg |
Market Status | Tentative Approval; Prescription |
Company | Wockhardt; Mylan Pharms; Hetero Labs Ltd V; Teva Parenteral; Teva; Apotex; Aurobindo Pharma; Torrent Pharms; Sun Pharma Global; Perrigo R And D; Actavis Elizabeth; Macleods Pharms; Jubilant Generics; Kudco Ireland; Ranbaxy Labs; Dr Reddys Labs; Akorn |
2 of 4 | |
---|---|
Drug Name | Protonix iv |
Active Ingredient | Pantoprazole sodium |
Dosage Form | Injectable |
Route | Iv (infusion) |
Strength | eq 40mg base/vial |
Market Status | Prescription |
Company | Wyeth Pharms |
3 of 4 | |
---|---|
Drug Name | Pantoprazole sodium |
Drug Label | The active ingredient in pantoprazole sodium delayed-release tablets USP is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid... |
Active Ingredient | Pantoprazole sodium |
Dosage Form | Injectable; Tablet, delayed release |
Route | injection; Iv (infusion); Oral |
Strength | eq 20mg base; eq 40mg base/vial; eq 40mg base; 40mg |
Market Status | Tentative Approval; Prescription |
Company | Wockhardt; Mylan Pharms; Hetero Labs Ltd V; Teva Parenteral; Teva; Apotex; Aurobindo Pharma; Torrent Pharms; Sun Pharma Global; Perrigo R And D; Actavis Elizabeth; Macleods Pharms; Jubilant Generics; Kudco Ireland; Ranbaxy Labs; Dr Reddys Labs; Akorn |
4 of 4 | |
---|---|
Drug Name | Protonix iv |
Active Ingredient | Pantoprazole sodium |
Dosage Form | Injectable |
Route | Iv (infusion) |
Strength | eq 40mg base/vial |
Market Status | Prescription |
Company | Wyeth Pharms |
Short-term treatment of reflux symptoms (e. g. heartburn, acid regurgitation) in adults.
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
Proton Pump Inhibitors
Compounds that inhibit H(+)-K(+)-EXCHANGING ATPASE. They are used as ANTI-ULCER AGENTS and sometimes in place of HISTAMINE H2 ANTAGONISTS for GASTROESOPHAGEAL REFLUX. (See all compounds classified as Proton Pump Inhibitors.)
A02BC02
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36375
Submission : 2021-12-28
Status : Active
Type : II
Certificate Number : CEP 2024-140 - Rev 00
Issue Date : 2024-06-10
Type : Chemical
Substance Number : 2296
Status : Valid
Date of Issue : 2025-02-27
Valid Till : 2028-03-17
Written Confirmation Number : WC-0004
Address of the Firm :
NDC Package Code : 49716-334
Start Marketing Date : 2023-10-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : RU |
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Certificate Number : CEP 2023-421 - Rev 00
Issue Date : 2024-07-16
Type : Chemical
Substance Number : 2296
Status : Valid
Date of Issue : 2024-08-16
Valid Till : 2027-02-26
Written Confirmation Number : WC-0494
Address of the Firm :
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35577
Submission : 2021-03-29
Status : Active
Type : II
Certificate Number : CEP 2021-168 - Rev 01
Issue Date : 2024-06-21
Type : Chemical
Substance Number : 2296
Status : Valid
Date of Issue : 2024-04-03
Valid Till : 2027-01-21
Written Confirmation Number : WC-0493
Address of the Firm :
NDC Package Code : 42765-001
Start Marketing Date : 2018-01-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-02-07
Pay. Date : 2019-02-01
DMF Number : 17103
Submission : 2004-01-20
Status : Active
Type : II
Certificate Number : R1-CEP 2010-319 - Rev 01
Issue Date : 2017-03-28
Type : Chemical
Substance Number : 2296
Status : Valid
Date of Issue : 2022-05-26
Valid Till : 2025-06-25
Written Confirmation Number : WC-0035
Address of the Firm :
NDC Package Code : 55111-051
Start Marketing Date : 2004-01-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-03-22
Pay. Date : 2019-03-11
DMF Number : 18779
Submission : 2005-09-15
Status : Active
Type : II
Certificate Number : R1-CEP 2009-323 - Rev 02
Issue Date : 2020-01-31
Type : Chemical
Substance Number : 2296
Status : Valid
NDC Package Code : 68069-0005
Start Marketing Date : 2010-07-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36375
Submission : 2021-12-28
Status : Active
Type : II
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35577
Submission : 2021-03-29
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-27
Pay. Date : 2020-03-23
DMF Number : 24813
Submission : 2011-03-31
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2019-02-07
Pay. Date : 2019-02-01
DMF Number : 17103
Submission : 2004-01-20
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2019-03-22
Pay. Date : 2019-03-11
DMF Number : 18779
Submission : 2005-09-15
Status : Active
Type : II
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15886
Submission : 2002-02-28
Status : Active
Type : II
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
GDUFA
DMF Review : Complete
Rev. Date : 2023-05-04
Pay. Date : 2023-04-18
DMF Number : 36849
Submission : 2022-05-19
Status : Active
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 19917
Submission : 2006-10-30
Status : Inactive
Type : II
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
GDUFA
DMF Review : Complete
Rev. Date : 2012-11-23
Pay. Date : 2012-11-13
DMF Number : 17118
Submission : 2004-01-26
Status : Active
Type : II
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36393
Submission : 2021-10-18
Status : Active
Type : II
Pantoprazole Sodium Sesquihydrate, Process-II
Certificate Number : CEP 2024-140 - Rev 00
Status : Valid
Issue Date : 2024-06-10
Type : Chemical
Substance Number : 2296
Pantoprazole Sodium Sesquihydrate
Certificate Number : R0-CEP 2021-427 - Rev 00
Status : Valid
Issue Date : 2022-11-02
Type : Chemical
Substance Number : 2296
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Pantoprazole Sodium Sesquihydrate
Certificate Number : CEP 2023-421 - Rev 00
Status : Valid
Issue Date : 2024-07-16
Type : Chemical
Substance Number : 2296
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Pantoprazole Sodium Sesquihydrate, PAS Process
Certificate Number : CEP 2023-127 - Rev 01
Status : Valid
Issue Date : 2024-06-21
Type : Chemical
Substance Number : 2296
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Pantoprazole Sodium Sesquihydrate
Certificate Number : CEP 2021-168 - Rev 01
Status : Valid
Issue Date : 2024-06-21
Type : Chemical
Substance Number : 2296
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Pantoprazole Sodium Sesquihydrate
Certificate Number : R1-CEP 2010-319 - Rev 01
Status : Valid
Issue Date : 2017-03-28
Type : Chemical
Substance Number : 2296
Pantoprazole Sodium Sesquihydrate
Certificate Number : R1-CEP 2009-323 - Rev 02
Status : Valid
Issue Date : 2020-01-31
Type : Chemical
Substance Number : 2296
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
Pantoprazole Sodium Sesquihydrate
Certificate Number : CEP 2008-065 - Rev 03
Status : Valid
Issue Date : 2024-09-02
Type : Chemical
Substance Number : 2296
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Pantoprazole Sodium Sesquihydrate, Form-I
Certificate Number : CEP 2022-383 - Rev 00
Status : Valid
Issue Date : 2024-08-07
Type : Chemical
Substance Number : 2296
Pantoprazole Sodium Sesquihydrate
Certificate Number : R0-CEP 2009-046 - Rev 00
Status : Expired
Issue Date : 2010-07-21
Type : Chemical
Substance Number : 2296
Date of Issue : 2025-02-27
Valid Till : 2028-03-17
Written Confirmation Number : WC-0004
Address of the Firm : Village Fatehgarh Channa Mansa Road (Trident Complex), Barnala, District Barnala...
Pantoprazole Sodium Sesquihydrate BP/Ph. Eur.
Date of Issue : 2025-02-27
Valid Till : 2028-03-17
Written Confirmation Number : WC-0004
Address of the Firm : Village Fatehgarh Channa Mansa Road (Trident Complex), Barnala, District Barnala...
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Pantoprazole Sodium Sesqui Hydrate IP/USP/Ph.Eur
Date of Issue : 2024-08-16
Valid Till : 2027-02-26
Written Confirmation Number : WC-0494
Address of the Firm : (Unit-1), Sy No 29, Tupakulagudem (V), Pochavaram Panchayat, Tallapudi (M), West...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Pantoprazole Sodium Sesquihydrate Ph.Eur.
Date of Issue : 2024-04-03
Valid Till : 2027-01-21
Written Confirmation Number : WC-0493
Address of the Firm : Unit-IV, Plot No: 34B, 40B & 60B, J.N. Pharma City, Thanam (V), Parawada (M), An...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Pantoprazole Sodium Sesquihydrate Ph. Eur.
Date of Issue : 2022-05-26
Valid Till : 2025-06-25
Written Confirmation Number : WC-0035
Address of the Firm : Unit-lll, Plot No. 116, Sri Venkateswara Co-operative, Industrial Estate, IDA, B...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-05-26
Valid Till : 2025-06-25
Written Confirmation Number : WC-0035
Address of the Firm : Unit-lll, Plot No. 116, Sri Venkateswara Co-operative, Industrial Estate, IDA, B...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm : Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Man...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Pantoprazole Sodium Sesquihydrate Ph.Eur
Date of Issue : 2022-05-27
Valid Till : 2025-06-04
Written Confirmation Number : WC-0043
Address of the Firm : Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Man...
Pantoprazole Sodium (Sesquihydrate) Ph. Eur
Date of Issue : 2022-06-08
Valid Till : 2025-06-02
Written Confirmation Number : WC-0011nA2
Address of the Firm : Village Toansa, P.O. Rail Majra, District Shaheed Bhagat Singh Nagar, Panjab, In...
Date of Issue : 2022-06-08
Valid Till : 2025-06-02
Written Confirmation Number : WC-0011nA2
Address of the Firm : Village Toansa, P.O. Rail Majra, District Shaheed Bhagat Singh Nagar, Panjab, In...
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
Pantoprazole sodium sesquihydrate
Registrant Name : Korea Takeda Pharmaceutical Co., Ltd.
Registration Date : 2022-04-18
Registration Number : 20220418-209-J-1270
Manufacturer Name : PMC ISOCHEM
Manufacturer Address : 4 Rue Marc Sangnier, 45300 PITHIVIERS, France
Pantoprazole sodium sesquihydrate
Registrant Name : Dong-A ST Co., Ltd.
Registration Date : 2021-03-04
Registration Number : 20210304-209-J-855
Manufacturer Name : Apitoria Pharma Private Limi...
Manufacturer Address : Unit-I, Sy.No. 379, 385, 386, 388 - 396, Borpatla Village, Hatnoora Mandal, Sangaredd...
Pantoprazole sodium sesquihydrate
Registrant Name : UNUST Co., Ltd.
Registration Date : 2021-04-22
Registration Number : 20210422-209-J-949
Manufacturer Name : Cipla Limited
Manufacturer Address : Old Madras Road, Virgonagar Post, Bangalore-560 049, India
Pantoprazole sodium sesquihydrate
Registrant Name : Genewone Science Co., Ltd.
Registration Date : 2025-04-16
Registration Number : 20210422-209-J-949(1)
Manufacturer Name : Cipla Limited
Manufacturer Address : Old Madras Road, Virgonagar Post, Bangalore-560 049, India
Registrant Name : Lee Sung International Co., Ltd.
Registration Date : 2021-06-10
Registration Number : 20210610-209-J-1019
Manufacturer Name : Hetero Drugs Limited(Unit-I)
Manufacturer Address : Sy.No.213, 214 & 255, Bonthapally Village, Gummadidala Mandal Sangareddy District Tel...
Pantoprazole sodium sesquihydrate
Registrant Name : Toru Corporation
Registration Date : 2022-07-08
Registration Number : 20220708-209-J-1326
Manufacturer Name : Lee Pharma Limited
Manufacturer Address : Survey No. 10/G-1, Gaddapotharam Village Jinnaram Mandal, Sangareddy District Telanga...
S-pantoprazole sodium trihydrate
Registrant Name : MFC Corporation
Registration Date : 2023-01-12
Registration Number : 20230112-209-J-1436
Manufacturer Name : MFC Corporation
Manufacturer Address : 35 Cheongwon Industrial Complex 7-gil, Mado-myeon, Hwaseong-si, Gyeonggi-do
S-pantoprazole sodium trihydrate
Registrant Name : Ridox Bio Co., Ltd.
Registration Date : 2022-02-04
Registration Number : 20220204-209-J-1174
Manufacturer Name : Ridox Bio Co., Ltd.
Manufacturer Address : 83, Yakjakgongdan 3-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
Registrant Name : Hyundai Bioland Co., Ltd.
Registration Date : 2021-04-14
Registration Number : 20180817-209-J-88(4)
Manufacturer Name : Vasudha Pharma Chem Limited,...
Manufacturer Address : Unit-II, Plot No.79, Jawaharlal Nehru Pharma City, Thanam Village, Parawada Mandal, A...
Registrant Name : Hanyoung Farm Co., Ltd.
Registration Date : 2023-03-10
Registration Number : 20180817-209-J-88(5)
Manufacturer Name : Vasudha Pharma Chem Limited
Manufacturer Address : Unit-II, Plot No. 79, Jawaharlal Nehru Pharma City, Thanam(V), Parawada, Visakhapatna...
NDC Package Code : 49716-334
Start Marketing Date : 2023-10-15
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
NDC Package Code : 42765-001
Start Marketing Date : 2018-01-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-051
Start Marketing Date : 2004-01-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68069-0005
Start Marketing Date : 2010-07-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.
NDC Package Code : 49632-160
Start Marketing Date : 2014-03-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
NDC Package Code : 62207-981
Start Marketing Date : 2022-05-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59651-953
Start Marketing Date : 2024-04-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-426
Start Marketing Date : 2023-11-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69575-4047
Start Marketing Date : 2021-12-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66174-0038
Start Marketing Date : 2014-02-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
About the Company : With a history spanning over three decades, IOL Chemicals and Pharmaceuticals Limited is an innovation-driven company that specializes in bulk drugs, intermediates and specialty ch...
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
About the Company : Tagoor Laboratories, established in 2018, is a part of the Tagoor Group. It specializes in providing APIs, advanced intermediates and key starting materials for critical and high-g...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
About the Company : Established in 1994, Rochem is a distributor of pharmaceutical, food, nutritional and animal health ingredients to some of the largest companies in the world. It sources high-quali...
About the Company : DKSH, founded with the goal of improving people's lives, assists businesses with market expansion and business growth in both existing and emerging markets. It has been fostering g...
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
About the Company : Founded in 1984, DRL is well-known for its generic APIs and its track record in drug product development. It is one of the earliest pharma API manufacturers with a diverse portfoli...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
Pantoprazole Sodium Sesquihydrate
About the Company : Gonane Pharma, is a contract pharmaceutical company located in Gujarat, India, specializing in the manufacturing and marketing of Corticosteroids, Hormones, Antivirals, and Oncolog...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 ...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Pantoprazole Sodium Delayed-Release tablets are indicated for short-term treatment of Erosive Esophagitis Associated with GERD and Pathological Hypersecretory Conditions.
Lead Product(s): Pantoprazole Sodium
Therapeutic Area: Gastroenterology Brand Name: Protonix-Generic
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable December 13, 2023
Lead Product(s) : Pantoprazole Sodium
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Granules India Limited Received ANDA Approval for Pantoprazole Sod Delayed-Release Tablets
Details : Pantoprazole Sodium Delayed-Release tablets are indicated for short-term treatment of Erosive Esophagitis Associated with GERD and Pathological Hypersecretory Conditions.
Product Name : Protonix-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 13, 2023
Details:
Protonix IV-Generic is a potassium-transporting ATPase inhibitor, small molecule drug candidate, which is indicated for the treatment of gastroesophageal reflux disease.
Lead Product(s): Pantoprazole Sodium
Therapeutic Area: Gastroenterology Brand Name: Protonix IV-Generic
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 03, 2025
Lead Product(s) : Pantoprazole Sodium
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Alembic announces USFDA final approval for Pantoprazole Sodium for Injection, 40 mg/vial
Details : Protonix IV-Generic is a potassium-transporting ATPase inhibitor, small molecule drug candidate, which is indicated for the treatment of gastroesophageal reflux disease.
Product Name : Protonix IV-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 03, 2025
Details:
OPENTOP D (pantoprazole Sodium and domperidone) Delayed-Release tablets are indicated for short-term treatment of Erosive Esophagitis Associated with GERD.
Lead Product(s): Pantoprazole Sodium,Domperidone
Therapeutic Area: Gastroenterology Brand Name: Opentop D
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Inapplicable
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 28, 2024
Lead Product(s) : Pantoprazole Sodium,Domperidone
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Royal Sense Launches Multiple Products in Pharmaceutical Category
Details : OPENTOP D (pantoprazole Sodium and domperidone) Delayed-Release tablets are indicated for short-term treatment of Erosive Esophagitis Associated with GERD.
Product Name : Opentop D
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 28, 2024
Details:
Sandoz has shipped pantoprazole sodium for injection, 40 mg to Civica Rx to supply the hospitals it serves as part of a multiyear collaboration to help reduce supply shortages, with several other medicines on the way before the end of the year.
Lead Product(s): Pantoprazole Sodium
Therapeutic Area: Gastroenterology Brand Name: Pantoprazole Sodium-Generic
Study Phase: Approved FDFProduct Type: Other Small Molecule
Sponsor: Civica Rx
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration February 11, 2020
Lead Product(s) : Pantoprazole Sodium
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Civica Rx
Deal Size : Undisclosed
Deal Type : Collaboration
Sandoz Ships First Medicine in Collaboration with Civica Rx to Supply Us Hospitals
Details : Sandoz has shipped pantoprazole sodium for injection, 40 mg to Civica Rx to supply the hospitals it serves as part of a multiyear collaboration to help reduce supply shortages, with several other medicines on the way before the end of the year.
Product Name : Pantoprazole Sodium-Generic
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
February 11, 2020
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Aspen Pantoprazole IV
Dosage Form : POI
Dosage Strength : 40mg / 10 ml
Packaging : 10X5mg / 10 ml
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code : AB
Brand Name : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 20MG BASE
Approval Date : 2023-12-11
Application Number : 217282
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
RLD : No
TE Code : AB
Brand Name : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 40MG BASE
Approval Date : 2023-12-11
Application Number : 217282
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
RLD : No
TE Code : AB
Brand Name : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 40MG BASE
Approval Date : 2022-07-26
Application Number : 215880
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
RLD : No
TE Code :
Brand Name : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 20MG BASE
Approval Date : 2024-04-25
Application Number : 215880
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
Brand Name : PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 40MG BASE/50ML (EQ 0.8MG BASE/ML)
Approval Date : 2024-02-14
Application Number : 217512
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Brand Name : PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : EQ 80MG BASE/100ML (EQ 0.8MG BASE/ML)
Approval Date : 2024-02-14
Application Number : 217512
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : No
TE Code : AP
Brand Name : PANTOPRAZOLE SODIUM
Dosage Form : INJECTABLE;INTRAVENOUS
Dosage Strength : EQ 40MG BASE/VIAL
Approval Date : 2022-05-19
Application Number : 214680
RX/OTC/DISCN : RX
RLD : No
TE Code : AP
RLD : No
TE Code :
Brand Name : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 20MG BASE
Approval Date : 2014-05-07
Application Number : 203024
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 40MG BASE
Approval Date : 2007-09-10
Application Number : 77058
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : PANTOPRAZOLE SODIUM
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : EQ 20MG BASE
Approval Date : 2012-05-02
Application Number : 200794
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 20mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Pantoprazole Zentiva
Dosage Form : Filmtabl
Dosage Strength : 40mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Enteric Coated Tablet
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Capsule
Grade : Oral
Brand Name : Sodium Stearyl Fumarate G...
Application : Lubricants & Glidants
Excipient Details : Sodium Stearyl Fumarate is used as a lubricant in OSDs to reduce the friction and the adhesion. It also provides tablet strength & disintegration.
Pharmacopoeia Ref : USP, EP, ICH, Q7GMP
Technical Specs : NA
Ingredient(s) : Sodium Stearyl Fumarate
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : CM90 is a directly compressible, granulated calcium carbonate with maltodextrin used for swallow tablets due to its high density and compressibility.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 490- 500 µm; Tapped Density: 1.50
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : Mannogem 2080 exhibits excellent flow, disintegration and compression properties.
Dosage Form : Orodispersible Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-170 µm, Tapped Density: 0.80
Ingredient(s) : Magnesium Hydroxide Excipient
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : Mannitol is a co-processed excipient with superior compactibility, lower disintegration time, and hygroscopicity.
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral and Topical
Brand Name : Calcium carbonate
Application : Fillers, Diluents & Binders
Excipient Details : Calcium Carbonate is used as buffering agent, Antacid, Calcium Supplement. It is also used as Dry binder, diluents and dissolution aid in tablets.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral & Topical
Application : Controlled & Modified Release
Excipient Details : Talc is a widely used as a dissolution retardant in the development of controlled release products. Talc is also used as a lubricant in tablet formulations.
Dosage Form : Tablet
Grade : Oral
Dosage Form : Capsule
Grade : Oral
Brand Name : Lumacril L-100D 55
Application : Controlled & Modified Release
Excipient Details : Lumacril L-100D 55 is an anionic copolymer used in delayed & sustained release coatings to enhance solubility for poorly soluble drugs in OSDs.
Pharmacopoeia Ref : USP-NF, Ph.Eur, BP, JP
Technical Specs : NA
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Oral, Topical & Parenteral
Brand Name : PEG/Macrogol 4000
Application : Emulsifying Agents
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Polyethylene Glycol 4000
Dosage Form : Tablet
Grade : Not Available
Application : Controlled & Modified Release
Excipient Details : Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying
Dosage Form : Tablet
Grade : Not Available
Application : Solubilizers
Excipient Details : Solubilization, dispersion, crystallization inhibition, instant release matrices & spray drying
Pharmacopoeia Ref : Ph. Eur., USP, JP: Povidone
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Capsule
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Tablet binding, thickener, stabilizers of suspensions, reduces sedimentation, crystallization inhibition.
Pharmacopoeia Ref : Ph. Eur., USP, JP: Povidone
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Granule / Pellet
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : Maximum disintegration
Pharmacopoeia Ref : Ph. Eur., USP, JP: Crospovidon...
Technical Specs : Not Available
Ingredient(s) : Polyvinylpyrrolidone Crosslinked
Dosage Form : Capsule
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : Kollidon CL-F has a balance of strong disintegration and optimal surface homogeneity.
Pharmacopoeia Ref : Ph. Eur., USP, JP: Crospovidon...
Technical Specs : Not Available
Ingredient(s) : Polyvinylpyrrolidone Crosslinked
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Excipient Details : For non-erodible matrices using direct compression, Controlled release matrix. Matrix former in transdermal patches and topical films.
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP-JPE: 80 %...
Technical Specs : Not Available
Ingredient(s) : Povidone
Dosage Form : Tablet
Grade : Not Available
Application : Film Formers & Plasticizers
Excipient Details : Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Propylene Glycol
Dosage Form : Softgel Capsule
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : Structure-building consistency factor with dry feel, forms crystalline barrier on skin
Pharmacopoeia Ref : Ph. Eur., USP-NF, JP: Stearic ...
Technical Specs : Not Available
Ingredient(s) : Stearic Acid
Dosage Form : Orodispersible Tablet
Grade : Not Available
Application : Chewable & Orodispersible Aids
Excipient Details : Ludiflash is a ready-to-use orally disintegrating tablet (ODT) solution with superior mouthfeel.
Pharmacopoeia Ref : Ph. Eur., USP, JP: 90 % mannit...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Tablet
Grade : Not Available
Application : Granulation
Excipient Details : Ready-to-use direct compression solution for tablets.
Pharmacopoeia Ref : Ph.Eur., USP/NF and JP
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Emulsion
Grade : Topical
Application : Rheology Modifiers
Excipient Details : Polyglykol 400 is a liquid PEG excipient grade product which is used as solvent, humectant, coating agent and viscosity enhancer.
Pharmacopoeia Ref : USP-NF: Polyethylene glycol 40...
Technical Specs : average molar mass 400 g/mol
Ingredient(s) : Polyethylene Glycol 400
Dosage Form : Tablet
Grade : Topical
Brand Name : Polyglykol 4000 PF
Application : Fillers, Diluents & Binders
Excipient Details : Polyglykol 4000 PF is a milled PEG excipient grade powder product with a fine particle size distribution which is used as binder in oral dosage forms.
Pharmacopoeia Ref : USP-NF: Polyethylene glycol 40...
Technical Specs : average molar mass 4000 g/mol
Ingredient(s) : Polyethylene Glycol 4000
Dosage Form : Tablet
Grade : Topical and Oral
Brand Name : Polyethylene Glycol 400
Application : Controlled & Modified Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : polyethylene glycol
Dosage Form : Cream / Lotion / Ointment
Grade : Topical and Oral
Application : Topical
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : F-Melt Type C is a pharmaceutical excipient used in oral dosage forms like orally disintegrating tablets, sachets, dispersible tablets, chewable tablets and sublingual tablets.
Pharmacopoeia Ref : Conforms to Japanese Pharmaceu...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : F-Melt Type M is used in various dosage forms like orally disintegrating tablets (ODTs), sachets, dispersible tablets, chewable tablets and sublingual formulations.
Pharmacopoeia Ref : Conforms to Japanese Pharmaceu...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Tablet
Grade : Oral
Application : Thickeners and Stabilizers
Excipient Details : Adsorbent, Moisture Protection, Stabilization of API
Pharmacopoeia Ref : USP-NF, JP, EP
Technical Specs : Also Available as FUJISIL-F
Ingredient(s) : Silicon Dioxide
Dosage Form : Ophthalmic Solution
Grade : Oral, Ophthalmic, Microsphere Injectable,Topical
Application : Parenteral
Excipient Details : Gohsenol EG acts as a pharmaceutical binder, filler and film former in various dosage forms like opthalmic, microsphere, OD strip and gel patches.
Pharmacopoeia Ref : JPE, USP, EP, ChP (China)
Technical Specs : Highly purified PVA, Partially hydrolysis, having all viscocity grade from 3cps to 48 cps.
Ingredient(s) : Polyvinyl Alcohol
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : USP-NF, EP, BP, IP, JP, FCC
Technical Specs : PVP K-K-30/ K-17/ K19/ K25/ K90
Ingredient(s) : Povidone
Dosage Form : Capsule
Grade : Oral
Application : Solubilizers
Excipient Details : Super disintegrate, solublity enhancer, Suspension stabilizer, Complexing agent, Low peroxide content, Long term stability
Pharmacopoeia Ref : Not Available
Technical Specs : Crospovidone (Type-A/B)- USP-NF / Ph. Eur. / BP / IP
Ingredient(s) : Crospovidone
Dosage Form : Capsule
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Enteric, Delayed Release Matrix and Solubility Enhancement
Pharmacopoeia Ref : Multicompendial
Technical Specs : Methylacryli acid and Ethyl Acrylate copolymer (1:1) Type A
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Ready mix Film coating system for moisture sensitive APIs
Pharmacopoeia Ref : USP, EP, JP; Having US-DMF
Technical Specs : Moisture barrier film coating system
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Capsule
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Ready mix Non-Functional film coating system.
Pharmacopoeia Ref : USP, EP, JP; Having US-DMF
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Emulsion
Grade : Topical
Application : Rheology Modifiers
Excipient Details : Thickener, Emulsifier, Stabilizer, Texturizing agent, pH Independent & Non Thixotropic polymer for Topical Range (Skin,Vaginal & Anal mucosa)
Pharmacopoeia Ref : In house having US DMF Type IV...
Technical Specs : Ready to use liquid polymer for topical applications (Gel / Cream / Lotion/ Foam based formulation, ...
Ingredient(s) : Hydroxyethyl Acrylate
Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Ecopol L 100 is used as an enteric/delayed release coating system and for drug delivery in the small intestine.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Ecopol L 30 D-55 is used as an enteric/delayed release coating system for drug delivery in the duodenum.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Ecopol L100 55 is an enteric/delayed release coating for drug delivery in the duodenum.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Ecopol S 100 is used as an enteric/delayed release coating system for drug delivery in colon.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Espheres EM can be used as an inert base for modified release formulations promoting uniformity of release profile.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Instacoat CFC is an HPMC & xylitol-based high-speed optimized chewable and crunchy film coating material.
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Instacoat EEN provides enteric protection at minimum weight gain, typically between 6.5 and 8.0%.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Instacoat EEN SF is a ready-to-use acrylic-based enteric coating formulation in dry powder form for reconstitution.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives
Excipient Details : Instacoat EMB is an excellent moisture barrier which reduces degradation of moisture sensitive APIs.
Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : Instamodel Blend is used to provide extended release from oral dosage forms.
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Mannitol is used as a filler and binder in the manufacturing of oral solid dosage forms such as tablets.
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : Sodium Starch Glycolate, Potato is used as a superdisintegrant in the oral dosage forms such as tablets.
Dosage Form : Emulsion
Grade : Oral, Topical
Application : Thickeners and Stabilizers
Excipient Details : Modified Starch, Corn is a white powder and a unique emulsion stabilising starch derived from waxy maize.
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : Fully Pregel Starch Corn is used as a binder in wet granulation in the manufacturing of tablets.
Pharmacopoeia Ref : USP/NF, Ph. Eur., Ch. P.
Technical Specs : NA
Ingredient(s) : Corn Starch, Pregelatinized
Dosage Form : Tablet
Grade : Not Available
Application : Co-Processed Excipients
Excipient Details : Direct Compression
Dosage Form : Tablet
Grade : Not Available
Application : Co-Processed Excipients
Excipient Details : Standard Direct Tabletting Or Roller Compaction
Dosage Form : Tablet
Grade : Not Available
Application : Co-Processed Excipients
Excipient Details : Direct Compression
Pharmacopoeia Ref : NF/EP/JP
Technical Specs : Not Available
Ingredient(s) : Spray Dried Monohydrate Lactose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Film Forming Agent, Wet/Dry Granulation- Binder,Thickening & Suspension Agent, Non-Gelatin Capsule Manufacturing & Enteric Film Coating Systems
Pharmacopoeia Ref : USP, EP, and JP
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Application : Controlled & Modified Release
Excipient Details : Sustained Release Tablet Matrix
Pharmacopoeia Ref : USP, EP, and JP
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Application : Controlled & Modified Release
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Polydextrose Sugar
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Enteric Coatings
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : EthylCellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Customized per requirements
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Tablet
Grade : Oral
Brand Name : Microcrystalline Cellulos...
Application : Fillers, Diluents & Binders
Excipient Details : Microcrystalline Cellulose is most commonly used filler and binder in drug formulations, together with Lactose.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Brand Name : Sodium Starch Glycolate
Application : Disintegrants & Superdisintegrants
Excipient Details : Sodium Starch Glycolate is widely used as a superdisintegrant in various oral dosage forms.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Sodium Starch Glycolate
Dosage Form : Emulsion
Grade : Oral, Ophthalmic
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Clinical Supply
Grade : Oral
Application : Empty Capsules
Excipient Details : DBcaps® capsules are developed with a tamper-evident design to specifically address the clinical trial challenges of testing without bias.
Pharmacopoeia Ref : Not Available
Technical Specs : Size # AAA- E
Ingredient(s) : Gelatin, Unspecified
Dosage Form : Capsule
Grade : Oral
Application : Vegetarian Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : Size # 0-1
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : HardGel
Grade : Oral
Application : Empty Capsules
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Gelatin, Unspecified
Dosage Form : Capsule
Grade : Oral
Application : Vegetarian Capsules
Pharmacopoeia Ref : Complies with relevant Europea...
Technical Specs : Water content – less than 6%; Size #0
Ingredient(s) : HPMC AS
Dosage Form : Capsule
Grade : Oral and Inhalation
Application : Vegetarian Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : "Water content – less than 9%, can be customized; Size # 00el - 4
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Inhalation
Grade : Inhalation
Application : Empty Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : Size # 00el - 4
Ingredient(s) : Gelatin, Unspecified
Dosage Form : Tablet
Grade : Topical, Oral
Application : Lubricants & Glidants
Excipient Details : A water repellent agent in the production of effervescent tablets to to prevent unwanted absorption of moisture.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...
Technical Specs : Specific Surface Area-5-9 m2/g; Particle Size-5-9 µm.
Ingredient(s) : Calcium Stearate
Dosage Form : Tablet
Grade : Topical, Oral
Application : Lubricants & Glidants
Excipient Details : Meets Kosher and Halal preparations in Jewish and Arab cultures.Qualified in high specification standards requested by European formulators.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...
Technical Specs : Not Available
Ingredient(s) : Calcium Stearate
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® HML C2910
Application : Coating Systems & Additives
Excipient Details : It is used in film coating of tablets due to its higher molecular weight and higher resistance to simulated gastric fluid, high degree of polymerisation.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...
Technical Specs : Also Available as Microlex® HML C2906, Microlex® HML C2208.
Ingredient(s) : Hypromellose
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® LCA 60.m
Application : Granulation
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Milled; Also Available as Microlex® LCA 120.m, Microlex® LCA 200.m
Ingredient(s) : Anhydrous Lactose
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® LCM 80.m
Application : Granulation
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Milled; Also Available as Microlex® LCM 180.m, Microlex® LCM 200.m
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® MCC 101
Application : Granulation
Excipient Details : Tablets made from these granules are typically easily disintegrated using conventional super disintegrates even when hard tablets are compressed.
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® MCC 102
Application : Direct Compression
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule
Grade : Topical, Oral
Brand Name : Microlex® MLP 520
Application : Fillers, Diluents & Binders
Excipient Details : Use in a wide range of oral applications such as wet or dry granulation, excipient of choice for flash release forms.
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF
Technical Specs : Available in different particle size as 25.µ, 50.µ, 180.µ
Ingredient(s) : Mannitol
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® PVD K30
Application : Solubilizers
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Also Available as Microlex® PVD K90.
Ingredient(s) : Povidone
Dosage Form : Tablet
Grade : Topical, Oral
Application : Lubricants & Glidants
Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF, JP/...
Technical Specs : Not Available
Ingredient(s) : Stearic Acid
Dosage Form : Tablet
Grade : Oral, Topical & Parenteral
Application : Solubilizers
Excipient Details : Polysorbate 80 acts as solubilizer, emulsifier and wetting agent.
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : NOVALUBE SODIUM STEARYL FUMARATE is a Hydrophilic Lubricant, suitable for API’s with poor water solubility & incompatibility with magnesium stearate.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Sodium Stearyl Fumarate
Dosage Form : Tablet
Grade : Oral
Application : Fillers, Diluents & Binders
Excipient Details : TABCELL serves as an excellent excipient for solid dosage forms, providing numerous advantages for tablet formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Dosage Form : Capsule
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : They are references multipurpose superdisintegrants, well-known and widely used in the pharmaceutical industry.
Pharmacopoeia Ref : EP/USP/JPE
Technical Specs : Not Available
Ingredient(s) : Sodium Starch Glycolate, Potato
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : It is a natural pregelatinized maize starch that has been specially developed as a binder for wet granulation.
Dosage Form : Tablet
Grade : Not Available
Application : Disintegrants & Superdisintegrants
Excipient Details : Used as disintegrants, fillers and binders (once cooked) in nutraceutical and pharmaceutical dosage forms.
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Helps to manufacture Oral Dosage and Nutraceutical forms by acting as a filler-binder while serving as a fibre source for your customers.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Its range offers a unique blend of exceptional physical and chemical stability and no hygroscopicity.
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Dosage Form : Tablet
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : Used as disintegrants, fillers and binders (once cooked) in nutraceutical and pharmaceutical dosage forms.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Corn Starch, Colloidal Silica
Dosage Form : Capsule
Grade : Not Available
Application : Fillers, Diluents & Binders
Excipient Details : It is a Co-Processed Lactose starch for filler/binder having strong disintegrant properties.
Dosage Form : Cream / Lotion / Ointment
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : A co-processed product used as a secondary stabilizer and suspension agent in semi-solides formulas.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Colloidal Microcrystalline Cellulose
Dosage Form : Cream / Lotion / Ointment
Grade : Not Available
Application : Thickeners and Stabilizers
Excipient Details : A co-processed product used as a secondary stabilizer and suspension agent in semi-solides formulas.
Pharmacopoeia Ref : EP/USP/JP
Technical Specs : Not Available
Ingredient(s) : Colloidal Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : AceCel is suitable for majority of the directly compressible actives, combines good flow and high compressibility.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : HiCel acts as a strong dry binder. It facilitates low tablet friability & promotes rapid tablet disintegration.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : HiCel CE15 offers a superior mouthfeel with less chalkiness and gritness in chewable tablets and orally disintegrating tablets (ODTs).
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Guar Gum Excipient
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Brand Name : HiCel MCC Spheres
Application : Co-Processed Excipients
Excipient Details : HiCel MCC Spheres are extremely versatile which are used for controlled release or sustained release formulations.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : HiCel MCG is use in oral suspensions as a stabilizer. It is a good binder for tablets & excellent thickener as well.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Carboxymethyl cellulose sodium
Dosage Form : Tablet
Grade : Oral
Application : Co-Processed Excipients
Excipient Details : HiCel SMCC has unique combination which result in optimum compaction & superior flow properties.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose
Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : HiCellac is used in direct compression & dry granulation suitable for low dose formulations where API content uniformity is critical.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : Puretalc is used as a lubricant & diluent in oral solid dosage formulations such as tablets.
Dosage Form : Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : Stargel is used in oral pharmaceuticals as a disintegrant in tablet and capsules formulations. It is also used as a suspending agent & stabilizer.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Sodium Starch Glycolate
Dosage Form : Solution
Grade : Oral, Topical
Application : Solubilizers
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : Polygit E100 is used as a taste and odor masking agent in oral solid immediate-release formulations such as pellets and tablets.
Pharmacopoeia Ref : USP/NF, JPE, Ph. Eur.
Technical Specs : Soluble in gastric fluid up to pH 5
Ingredient(s) : Amino Methacrylate Copolymer
Dosage Form : Suspension
Grade : Oral
Application : Taste Masking
Excipient Details : PolyIon 900 is used as a taste masking agent in liquid dosage forms including suspensions and dry syrups and in oral solids such as tablets.
Pharmacopoeia Ref : In-house
Technical Specs : N/A
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Tablet
Grade : Oral
Application : Lubricants & Glidants
Excipient Details : Calcium stearate is used as lubricants and glidants in the formulation of tablets and capsules.
Dosage Form : Capsule
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Dosage Form : Granule / Pellet
Grade : Oral
Excipients by Applications
Application : API Stability Enhancers, Thickeners and Stabilizers
Excipient Details : Adsorbent, Moisture Protection, Stabilization of API
Pharmacopoeia Ref : USP-NF, JP, EP
Technical Specs : Also Available as FUJISIL-F
Ingredient(s) : Silicon Dioxide
Grade : Not Available
Category : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Application : API Stability Enhancers, Coating Systems & Additives, Controlled & Modified Release, Direct Compression, Granulation, Rheology Modifiers, Vegetarian Capsules
Excipient Details : Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methylcellulose
Dosage Form : Capsule
Grade : Oral and Inhalation
Category : API Stability Enhancers, Vegetarian Capsules
Application : API Stability Enhancers, Vegetarian Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : "Water content – less than 9%, can be customized; Size # 00el -...
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Capsule
Grade : Oral
Category : API Stability Enhancers, Taste Masking, Vegetarian Capsules
Application : API Stability Enhancers, Taste Masking, Vegetarian Capsules
Pharmacopoeia Ref : Certified Vegan, Non-GMO, Vege...
Technical Specs : Size # 0-1
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Capsule, Tablet, Dry Syrup
Grade : Oral
Category : Co-Processed Excipients, Direct Compression, Solubilizers
Application : Co-Processed Excipients, Direct Compression, Solubilizers
Excipient Details : Solubilizer
Pharmacopoeia Ref : Not Available
Technical Specs : Solubilizer in powder form; EXCiPACT
Ingredient(s) : Polysorbate 80
Grade : Oral
Category : API Stability Enhancers, Direct Compression, Solubilizers
Application : API Stability Enhancers, Direct Compression, Solubilizers
Excipient Details : Polysorbate 80 in dry powder form, a solubilizing agent acts as a surfactant and increases the solubility of various oral dosage forms.
Pharmacopoeia Ref : USP-NF, EP, JP & having US DMF
Technical Specs : Solubilizer in powder form, used in directly compressible dosage ...
Ingredient(s) : Magnesium aluminium silicate Excipient
Global Sales Information
Market Place
Reply
22 May 2025
Reply
12 Apr 2025
Reply
12 Mar 2025
Reply
27 Dec 2024
Reply
24 Dec 2024
Reply
07 Dec 2024
Reply
07 Nov 2024
Reply
30 Sep 2024
Reply
24 Sep 2024
Reply
16 Sep 2024
Patents & EXCLUSIVITIES
Patent Expiration Date : 2025-03-30
US Patent Number : 7838027*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22020
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-03-30
Patent Expiration Date : 2025-03-30
US Patent Number : 7553498*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22020
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-03-30
Patent Expiration Date : 2025-03-30
US Patent Number : 7550153*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22020
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2025-03-30
Patent Expiration Date : 2026-12-07
US Patent Number : 7544370*PED
Drug Substance Claim :
Drug Product Claim :
Application Number : 22020
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-12-07
Patent Expiration Date : 2026-06-07
US Patent Number : 7544370
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 22020
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-06-07
Exclusivity Code : NPP
Exclusivity Expiration Date : 2027-08-12
Application Number : 20988
Product Number : 1
Exclusivity Details :
Patent Expiration Date : 2021-11-17
Date Granted : 2006-05-23
Brand Name : PANTO IV
Patent Number : 2428870
Filing Date : 2001-11-17
Strength per Unit : 40mg
Dosage Form : Lyophilized Powder
Human Or VET : Human
Route of Administration : Intravenous Injection
Patent Expiration Date : 2021-11-17
Date Granted : 2006-05-23
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Brand Name : PANTO-BYK
Patent Number : 2310585
Filing Date : 1998-12-08
Strength per Unit : 40mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Brand Name : PANTOLOC
Patent Number : 2310585
Filing Date : 1998-12-08
Strength per Unit : 20mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Brand Name : PANTOLOC
Patent Number : 2310585
Filing Date : 1998-12-08
Strength per Unit : 40mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Brand Name : PANTO-BYK
Patent Number : 2310585
Filing Date : 1998-12-08
Strength per Unit : 20mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2018-12-08
Date Granted : 2005-08-23
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Brand Name : PANTO-BYK
Patent Number : 2092694
Filing Date : 1991-09-06
Strength per Unit : 40mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2012-06-13
Date Granted : 2005-11-22
Brand Name : PANTO-BYK
Patent Number : 2109697
Filing Date : 1992-06-13
Strength per Unit : 40mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-06-13
Date Granted : 2005-11-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Brand Name : PANTOLOC
Patent Number : 2092694
Filing Date : 1991-09-06
Strength per Unit : 20mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2012-06-13
Date Granted : 2005-11-22
Brand Name : PANTOLOC
Patent Number : 2109697
Filing Date : 1992-06-13
Strength per Unit : 20mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2012-06-13
Date Granted : 2005-11-22
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Brand Name : PANTOLOC
Patent Number : 2092694
Filing Date : 1991-09-06
Strength per Unit : 40mg
Dosage Form : Enteric Coated Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2011-09-06
Date Granted : 2005-04-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
REF. STANDARDS & IMPURITIES
ANALYTICAL
Analyte : Pantoprazole
Method : LSMS/MS
LLOQ : 20
Units : ng/mL
Details : Human Plasma
ABOUT THIS PAGE
84
PharmaCompass offers a list of Pantoprazole Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pantoprazole Sodium manufacturer or Pantoprazole Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pantoprazole Sodium manufacturer or Pantoprazole Sodium supplier.
PharmaCompass also assists you with knowing the Pantoprazole Sodium API Price utilized in the formulation of products. Pantoprazole Sodium API Price is not always fixed or binding as the Pantoprazole Sodium Price is obtained through a variety of data sources. The Pantoprazole Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Nolpaza manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Nolpaza, including repackagers and relabelers. The FDA regulates Nolpaza manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Nolpaza API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Nolpaza manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Nolpaza supplier is an individual or a company that provides Nolpaza active pharmaceutical ingredient (API) or Nolpaza finished formulations upon request. The Nolpaza suppliers may include Nolpaza API manufacturers, exporters, distributors and traders.
click here to find a list of Nolpaza suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Nolpaza DMF (Drug Master File) is a document detailing the whole manufacturing process of Nolpaza active pharmaceutical ingredient (API) in detail. Different forms of Nolpaza DMFs exist exist since differing nations have different regulations, such as Nolpaza USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Nolpaza DMF submitted to regulatory agencies in the US is known as a USDMF. Nolpaza USDMF includes data on Nolpaza's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Nolpaza USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Nolpaza suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nolpaza Drug Master File in Korea (Nolpaza KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nolpaza. The MFDS reviews the Nolpaza KDMF as part of the drug registration process and uses the information provided in the Nolpaza KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nolpaza KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nolpaza API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nolpaza suppliers with KDMF on PharmaCompass.
A Nolpaza CEP of the European Pharmacopoeia monograph is often referred to as a Nolpaza Certificate of Suitability (COS). The purpose of a Nolpaza CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Nolpaza EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Nolpaza to their clients by showing that a Nolpaza CEP has been issued for it. The manufacturer submits a Nolpaza CEP (COS) as part of the market authorization procedure, and it takes on the role of a Nolpaza CEP holder for the record. Additionally, the data presented in the Nolpaza CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Nolpaza DMF.
A Nolpaza CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Nolpaza CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Nolpaza suppliers with CEP (COS) on PharmaCompass.
A Nolpaza written confirmation (Nolpaza WC) is an official document issued by a regulatory agency to a Nolpaza manufacturer, verifying that the manufacturing facility of a Nolpaza active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Nolpaza APIs or Nolpaza finished pharmaceutical products to another nation, regulatory agencies frequently require a Nolpaza WC (written confirmation) as part of the regulatory process.
click here to find a list of Nolpaza suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Nolpaza as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Nolpaza API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Nolpaza as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Nolpaza and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Nolpaza NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Nolpaza suppliers with NDC on PharmaCompass.
Nolpaza Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Nolpaza GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Nolpaza GMP manufacturer or Nolpaza GMP API supplier for your needs.
A Nolpaza CoA (Certificate of Analysis) is a formal document that attests to Nolpaza's compliance with Nolpaza specifications and serves as a tool for batch-level quality control.
Nolpaza CoA mostly includes findings from lab analyses of a specific batch. For each Nolpaza CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Nolpaza may be tested according to a variety of international standards, such as European Pharmacopoeia (Nolpaza EP), Nolpaza JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Nolpaza USP).